Clinical Trial Update: Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study in adults with elevated LDL-cholesterol to evaluate the safety, tolerability, pharmacokinetics, and pharmacod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Ikaria Bioscience Pty Ltd | Conditions: To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other Comorbidities | Phase 1 | Status: COMPLETED